Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03255070
Title A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ambrx, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.